Amundi Asset Management US’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $69.5M | Sell |
|
|||||
|
2020
Q4 | $213M | Buy |
|
|||||
|
2020
Q3 | $148M | Buy |
|
|||||
|
2020
Q2 | $138M | Buy |
|
|||||
|
2020
Q1 | $63.7M | Sell |
|
|||||
|
2019
Q4 | $82.6M | Buy |
|
|||||
|
2019
Q3 | $48.4M | Sell |
|
|||||
|
2019
Q2 | $75.4M | Sell |
|
|||||
|
2019
Q1 | $110M | Buy |
|
|||||
|
2018
Q4 | $68.2K | Buy |
|
|||||
|
2018
Q3 | $72.9M | Buy |
|
|||||
|
2018
Q2 | $61.8M | Sell |
|
|||||
|
2018
Q1 | $109M | Sell |
|
|||||
|
2017
Q4 | $174M | Buy |
|
|||||
|
2017
Q3 | $10.8M | Buy |
|
|||||
|
2017
Q2 | $6.36M | Hold |
|
|||||
|
2017
Q1 | $6.33M | Hold |
|
|||||
|
2016
Q4 | $6.39M | Buy |
|
|||||
|
2016
Q3 | $5.02M | Sell |
|
|||||
|
2016
Q2 | $4.83M | Buy |
|
|||||
|
2016
Q1 | $5.75M | Sell |
|
|||||
|
2015
Q4 | $7.97M | Buy |
|
|||||
|
2015
Q3 | $5.01M | Hold |
|
|||||
|
2015
Q2 | $5.8M | Buy |
|
|||||
|
2015
Q1 | $5.54M | Buy |
|
|||||
|
2014
Q4 | $5.7M | Buy |
|
|||||
|
2014
Q3 | $5.06M | Sell |
|
|||||
|
2014
Q2 | $4.99M | Buy |
|
|||||
|
2014
Q1 | $4.79M | Buy |
|
|||||
|
2013
Q4 | $4.06M | Sell |
|
|||||
|
2013
Q3 | $9.87M | Buy |
|
|||||
|
2013
Q2 | $2.81M | Buy |
|